Fåhraeus Startup and Growth
VC Fund
Lund, Sweden
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Fåhraeus Startup and Growth invests in
Stages Fåhraeus Startup and Growth invests in
Countries Fåhraeus Startup and Growth invests in
Round sizes
Round size
- Seed
- $851k–$2.7M
- Series A
- $1.8M–$5.9M
- Venture - Series Unknown
- $1.1M–$7.3M
Investment Focus
Industry
- Medical 5 (36%)
- Health Care 4 (29%)
- Biotechnology 3 (21%)
- Software 2 (14%)
- Therapeutics 2 (14%)
Stage
- Seed 5 (36%)
- Venture - Series Unknown 4 (29%)
- Series A 2 (14%)
- Pre-Seed 1 (7%)
- Funding Round 1 (7%)
Country
- Sweden 11 (79%)
- Denmark 1 (7%)
- Finland 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs. | $5.6M / Venture - Series Unknown / Jun 16, 2026 | ||
| Fida Biosystems is a company that operates in the field of biotechnology and provides nanoparticle and protein analysis services. | $5.9M / Series A / Dec 15, 2025 | ||
| Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs. | $7.2M / Feb 03, 2025 | ||
| Speqta is a performance marketing company that owns and operates an advertising network as well as several digital products and services. | $5.4M / Post-IPO Equity / Mar 11, 2024 | ||
| Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical treatments with lifestyle coaching. The platform connects users with a team of experts, including doctors, dietitians, and personal trainers, to create individualized weight management plans. | $990.3K / Pre-Seed / Oct 14, 2022 | ||
| Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma. | $2M / Venture - Series Unknown / Jul 30, 2022 | ||
| Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases. | $1.8M / Series A / May 03, 2022 | ||
| Nygen Analytics offers cloud-based solutions for sustainable and cost-effective analysis of single-cell genomic data. | Seed / Mar 14, 2022 | ||
| Saveggy develops a bio-based edible vegan coating for fruit and vegetables eliminating plastic while keeping its protecting properties. | $851.5K / Seed / Feb 23, 2022 | ||
| Moroxite F develops a new fracture treatment method that improves the anchoring of implants in osteoporosis. | $1.1M / Venture - Series Unknown / Feb 18, 2022 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fåhraeus Startup and Growth invest in?
Fåhraeus Startup and Growth invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 14 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fåhraeus Startup and Growth's check size?
Fåhraeus Startup and Growth typically joins rounds of $851k–$2.7M at Seed, $1.8M–$5.9M at Series A and $1.1M–$7.3M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fåhraeus Startup and Growth participates in.
When did Fåhraeus Startup and Growth last invest?
The most recent investment recorded for Fåhraeus Startup and Growth closed in Jun 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
